Shaheen Wirk
Board Member
Tvardi Therapeutics, Inc. (TVRD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Shaheen Wirk
Shaheen Wirk is recorded as Board Member at Tvardi Therapeutics, Inc. (TVRD). Tvardi Therapeutics, Inc. reported in an 8-K filed April 15, 2025 that Shaheen Wirk was appointed Class III director, effective April 15, 2025.
“In accordance with the Merger Agreement, effective upon at the closing of the Merger on April 15, 2025, the board of directors and its committees were reconstituted, with Susan Shiff, Ph.D. and Michael Wyzga appointed as Class I directors, whose terms expire at the Company's 2027 annual meeting, Imran Alibhai, Ph.D., Cynthia Smith and Sujal Shah appointed as Class II directors, whose terms expire at the Company's 2025 annual meeting, and Wallace Hall and Shaheen Wirk, M.D. appointed as Class III directors, whose terms expire at the Company's 2026 annual meeting.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-04-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Tvardi Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Derek Chalmers CEO
- Imran Alibhai CEO, Board Member
- Imran Alibhai, Ph.D. CEO, Board Member
- Sujal Shah Chairman, Board Member
- Dan Conn CFO
- Dan Conn, J.D., M.B.A CFO
- Dan Conn, J.D., M.B.A. CFO
- Mani Mohindru CFO
- Ryan Maynard CFO
- Thomas Reilly CFO
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.